Transparency Initiatives Spread as Companies Acknowledge Rising Drug Costs

More than a dozen states are considering drug price transparency bills — most recently in California, where a state senate committee voted to advance legislation requiring drugmakers to disclose operating costs.
Source: Drug Industry Daily